Immediate Outcomes of Transcatheter Closure versus Surgical Ligation of Patent Ductus Arteriosus in Children at the Cardiac Center of Ethiopia (2012-2022): A Comparative Cross-Sectional Study

埃塞俄比亚心脏中心(2012-2022 年)儿童动脉导管未闭经导管封堵术与外科结扎术的近期疗效比较:一项横断面研究

阅读:1

Abstract

BACKGROUND: Transcatheter closure and surgical ligation of patent ductus arteriosus (PDA) are management options for PDA that have not spontaneously closed. However, studies reported the presence of complications and residual shunts in both Transcatheter closure and surgical ligation of PDA by themselves. In this study, the immediate outcomes of transcatheter closure of PDA versus surgical ligation of PDA were compared. METHODS: Comparative cross-sectional study conducted on children under 18 years of age who underwent transcatheter closure and surgical ligation of PDA at a cardiac center in Ethiopia from January 1, 2012, to January 1, 2022, by retrospectively reviewing the records from October 1, 2023, to November 1, 2023. 664 patients who underwent PDA closure, (n = 316) in the transcatheter closure group and (n = 348) patients in the surgical ligation group were included in this study. RESULT: The surgical ligation group patients were younger, and more proportion of patients had severe pulmonary hypertension. Overall complications were significantly higher with surgical ligation compared with transcatheter closure ((112 (35.4% vs 286 (71.9%)), p-value = 0.001)). Total mechanical ventilation time, intensive care unit(ICU) stay, and hospital stay were higher in the surgical ligation group with a p-value of 0.001 each. CONCLUSION: Transcatheter closure of PDA has lower overall complications and shorter mechanical ventilation time, lower ICU stay, and lower hospital stay. Given the lower number of overall complications, transcatheter closure of PDA has to be considered for selected patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。